Sponsor:
Alliance Foundation Trials, LLC.
Code:
NCT04486352
Conditions
Endometrial Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Atezolizumab - 28 Day Cycle
Bevacizumab
Ipatasertib
Talazoparib
Trastuzumab emtansine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Alliance Foundation Trials, LLC. on 2024-07-03.